COVID Supply Crunch Means Testing Delays Might Last a While
Public health and healthcare professionals warn of looming delays in non-COVID testing. Experts renew the plea for a national strategy.
Related Articles
Too Little Sleep Raises Health Risks for Teens With T1D
Sleeping for more than 7 hours at night may improve cardiometabolic health in patients with type 1 diabetes, especially teenagers, showed an analysis.
Earlier Inclisiran Gives Better Long-Term LDL Reductions
Results of VICTORION-INITIATE study suggest better results with inclisiran first and highlight “stunning undertreatment” of cholesterol in usual care of patients with CVD.
No Routine Cancer Screening Option? New MCED Tests May Help
Early data suggest that several new multicancer early detection tests can identify a range of cancers that lack routine screening options.
Patient âgé diabétique de type 2 : nouveautés dans la prise en charge
La prise en charge du patient diabétique de plus de 75 ans constitue un chapitre essentiel de la dernière révision de la prise de position…
Depression, Children: Identification and Management
This summary covers assessing people aged 5–18 years for depression and appropriate management strategies based on severity
Single-Dose Zilebesiran Cuts BP Out to 6 Months: KARDIA-2
This phase 2 study supports the potential for combining biannual dosing of zilebesiran with standard-of-care antihypertensives to achieve additive blood pressure reductions.
Complement 3 Glomerulopathy: 5 Things to Know
Complement 3 glomerulopathy is a very rare kidney disease requiring biopsy and specialized tests for diagnosis. These five things to know are crucial to understanding…
Medscape on LinkedIn: Are you optimizing aesthetic treatments for your patients with skin of…
Are you optimizing aesthetic treatments for your patients with skin of color? Join our faculty experts for a live conversation on social media to learn…
Dementia: Assessment, Management, and Support
This summary of the NICE dementia guidance covers diagnosis in non-specialist settings, pharmacological management, and managing non-cognitive symptoms
Coronary Sinus Reducer an Option for Intractable Angina?
A coronary sinus reducer met one of two primary endpoints by reducing refractory angina in the ORBITA-COSMIC trial, but not the second, improvement in perfusion.